Table 2.
Antipsychotic prescriptions and indications in a specialist child and adolescent eating disorders program.
| |
Number of prescriptions |
Indications |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dosage/day (M , range) | Pre-referral | During EDP | Anxiety | Agitation | Anxiety & agitation | Anxiety & insomnia | Depression & anxiety | Depression & PTSD | Depression & agitation | PTSD | Depression | Depression & insomnia | Depression & insomnia & affective dysregulation | OCD & anorexic ruminations |
| Olanzapine (6.8 mg, 2.5-15 mg) |
- |
7 |
2 |
3 |
1 |
- |
1 |
- |
- |
- |
- |
- |
- |
- |
| Quetiapine (56 mg, 12.5-200 mg) |
- |
24 |
7 |
4 |
3 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
| Risperidone (1 mg, NA) |
- |
1 |
- |
1 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Total | 32 | 9 (27%) | 8 (24%) | 4 (12%) | 2 (6%) | 2 (6%) | 1 (3%) | 1 (3%) | 1 (3%) | 1 (3%) | 1 (3%) | 1 (3%) | 1 (3%) | |